Pharmaceutical company Janssen launches HealthTech startup challenge; $110,000 up for grabs
Computer scientist Alan Kay once said, “The best way to predict the future is to invent it.”
This is the philosophy underlying Janssen Australia’s recently launched startup challenge – HaTCH (Health and Technology Challenge). With health and fitness becoming less of a priority to Australians, there’s no better time for a startup-style intervention. The reality we’re faced with at the moment is that although Australians are living longer (Women – 84 years; Men – 79 years), we’re not necessarily living healthier.
Chronic disease now places a significant strain on our healthcare system and our community. The cost of healthcare currently sits at $140 billion per year, which makes up 9.1 percent of Australia’s GDP (Gross Domestic Product). This is expected to increase.
Australian pharmaceutical company Janssen Australia is therefore looking for innovation that will inspire Australians actively manage their health and wellbeing at every stage in their life. The challenge is seeking innovative solutions – particularly in the areas of asthma, obesity, diabetes, cardiovascular health, dementia, drug and alcohol abuse, mental health, oncology, virology and immunology – that will improve:
- Early disease detection and monitoring;
- Access to and sharing of health information; and
- Connectivity between Australians and healthcare providers and services.
Four finalists of HaTCH will each receive $10,000 and will collaborate with industry experts to workshop their ideas and business plans. The winner will then be chosen to receive $100,000 to kickstart commercialisation of their idea.
The panel of healthcare and startup experts include muru-D’s Mick Liubinskas, Janssen’s Managing Director Chris Hourigan, Professor Mukesh Haikerwal AO, health executive Amit Vohra, and Partner at Strativity Group Cyrus Allen.
Applications close on October 3rd. To apply, visit www.janssenhatch.com.au.